0009

CQ Pharmaceutical Holding Inc. (000950)

Market Closed
8 Dec, 06:57
XSHE XSHE
¥
5. 42
-0.04
-0.73%
¥
9.12B Market Cap
- P/E Ratio
0% Div Yield
20,142,859 Volume
0.54 Eps
¥ 5.46
Previous Close
Day Range
5.4 5.5
Year Range
4.54 6.67
Want to track 000950 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

000950 closed today lower at ¥5.42, a decrease of 0.73% from yesterday's close, completing a monthly decrease of -0.91% or ¥0.05. Over the past 12 months, 000950 stock gained 0.74%.
000950 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0.07%. On average, the company has surpassed earnings expectations by 0.04%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).

000950 Chart

Similar

Tecon Biology Co., Ltd.
¥ 6.92
-0.57%
Shandong Yisheng Livestock Co., Ltd.
¥ 8.5
-0.23%
Chongqing Baiya Sanitary Products Co., Ltd.
¥ 20.27
+0.35%
Three Squirrels Inc.
¥ 22.82
-1.43%
Shenzhen Cereals Holdings Co., Ltd.
3.49 HKD
-0.29%

CQ Pharmaceutical Holding Inc. (000950) FAQ

What is the stock price today?

The current price is ¥5.42.

On which exchange is it traded?

CQ Pharmaceutical Holding Inc. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 000950.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 9.12B.

Has CQ Pharmaceutical Holding Inc. ever had a stock split?

No, there has never been a stock split.

CQ Pharmaceutical Holding Inc. Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Mr. Wei Liu CEO
XSHE Exchange
- ISIN
CN Country
13,820 Employees
- Last Dividend
16 Apr 2010 Last Split
26 Dec 2006 IPO Date

Overview

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical company that specializes in the distribution of a wide range of pharmaceutical products. Founded in 1999 and headquartered in Chongqing, China, the company has evolved from its original incarnation as the Southwest Branch of China Medicine Company. It now holds a significant position in the pharmaceutical industry, engaging in research, development, production, and investment of medical devices. C.Q. Pharmaceutical Holding Co., Ltd. aims to contribute to the healthcare sector through its expansive offerings that encompass medicines, medical devices, and health products, among other services. It focuses on innovation and quality, ensuring that its products and services meet the stringent demands of healthcare providers and patients alike.

Products and Services

  • Medicines
  • Includes a comprehensive range of prescription drugs and over-the-counter medications, catering to various therapeutic areas. These medicines are produced following rigorous quality standards to ensure efficacy and safety for patients.

  • Medical Devices
  • C.Q. Pharmaceutical Holding Co., Ltd. offers an extensive portfolio of medical devices used in diagnostic, therapeutic, and surgical applications. These devices are designed to meet the high standards of the healthcare industry, reflecting the company’s commitment to innovation and quality.

  • Chinese Herbal Medicines
  • The company embraces the traditional Chinese medical heritage by providing a selection of Chinese herbal medicines. These products combine ancient wisdom with modern manufacturing processes to offer effective and natural treatment options.

  • Health Products
  • Includes a variety of supplements and preventive care products designed to support overall health and wellness. These products are formulated to meet the nutritional needs and enhance the well-being of individuals.

  • Hospital Sales
  • C.Q. Pharmaceutical Holding Co., Ltd. works closely with hospitals, offering tailored pharmaceutical supply solutions. This service enables hospitals to efficiently manage their pharmaceutical needs, ensuring the availability of necessary medications and medical devices.

  • Commercial Wholesale, Retail Chain
  • The company operates a comprehensive commercial wholesale and retail chain. This network ensures the efficient distribution of pharmaceutical products to a wide range of customers, including pharmacies, healthcare providers, and end-users.

  • Terminal Distribution
  • Focuses on the direct distribution of pharmaceutical products to end-users. Terminal distribution services are critical in ensuring patients have timely access to medications and healthcare products.

  • Warehousing Logistics
  • Provides sophisticated warehousing and logistics services, designed to maintain the integrity and availability of pharmaceutical products throughout the supply chain. This service is central to the company’s operations, ensuring products are stored and transported under optimal conditions.

  • Supply Chain Value-Added Services
  • Includes a range of services designed to enhance the efficiency and effectiveness of the pharmaceutical supply chain. These services may involve inventory management, order processing, and distribution planning, contributing to the overall performance of the healthcare sector.

  • Auxiliary Medical Services
  • Comprises various support services that complement the core offerings, such as chronic disease management, electronic prescription circulation, outpatient pharmacy management, and remote diagnosis and treatment. These services leverage technology and innovation to improve patient care and healthcare delivery.

Contact Information

Address: No. 303, Jinshi Avenue, Chongqing, China, 400010
Phone: 86 23 6391 0671